Shop

Showing 993–1008 of 1229 results

Article: Radiation oncology for the medical oncologist
€3.03 Only for registered clients
Article: Radiation pneumonitis: occurrence, prediction, prevention and treatment
€3.03 Only for registered clients
Article: Radiation-induced collateral damage: impact on metastasis
€3.03 Only for registered clients
Article: Radiotherapy for metastatic colorectal cancer: When is it worth it?
€3.03 Only for registered clients
Article: Radiotherapy in the lung cancer immuno-oncology era
€3.03 Only for registered clients
Article: Radium-223 in metastatic castration-resistant prostate cancer: a single centre experience
€3.03 Only for registered clients
Article: Radium-223, patient selection is of utmost importance
€3.03 Only for registered clients
Article: Rapid PCR testing as adjunct to next-generation sequencing for the detection of alterations in patients with non-small-cell lung cancer
€3.03 Only for registered clients
Article: RAS-testing in colorectal cancer: Belgian guidelines
€3.03 Only for registered clients
Article: Reactivations of prior infections in cancer patients treated with immunosuppressive/immunomodulatory treatments
€3.03 Only for registered clients
Article: Real life cost of treatment and follow-up of patients with glioblastoma in Belgium: a retrospective patient chart review
€3.03 Only for registered clients
Article: Real-life outcome of optimally treated patients with malignant glioma
€3.03 Only for registered clients
Article: Real-life value of follow-up FDG-PET/CT (FU-FDG-PET/CT) in patients with locoregionally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) treated with chemoradiation (CRT) or (chemo)radiation ([C]RT) preceded by induction chemotherapy (IC) (sequential treatment [ST]).
€3.03 Only for registered clients
Article: Real-world evidence for implementation of new drugs
€3.03 Only for registered clients
Article: Real-world treatment practices for EGFR-mutant NSCLC patients
€3.03 Only for registered clients
Article: Rebuttal to ‘The COMPARZ study presented at ESMO 2012: how pliable is non-inferiority?’
€3.03 Only for registered clients

Article: Radiation oncology for the medical oncologist

Article: Radiation pneumonitis: occurrence, prediction, prevention and treatment

Article: Radiation-induced collateral damage: impact on metastasis

Article: Radiotherapy for metastatic colorectal cancer: When is it worth it?

Article: Radiotherapy in the lung cancer immuno-oncology era

Article: Radium-223 in metastatic castration-resistant prostate cancer: a single centre experience

Article: Radium-223, patient selection is of utmost importance

Article: Rapid PCR testing as adjunct to next-generation sequencing for the detection of alterations in patients with non-small-cell lung cancer

Article: RAS-testing in colorectal cancer: Belgian guidelines

Article: Reactivations of prior infections in cancer patients treated with immunosuppressive/immunomodulatory treatments

Article: Real life cost of treatment and follow-up of patients with glioblastoma in Belgium: a retrospective patient chart review

Article: Real-life outcome of optimally treated patients with malignant glioma

Article: Real-life value of follow-up FDG-PET/CT (FU-FDG-PET/CT) in patients with locoregionally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) treated with chemoradiation (CRT) or (chemo)radiation ([C]RT) preceded by induction chemotherapy (IC) (sequential treatment [ST]).

Article: Real-world evidence for implementation of new drugs

Article: Real-world treatment practices for EGFR-mutant NSCLC patients

Article: Rebuttal to ‘The COMPARZ study presented at ESMO 2012: how pliable is non-inferiority?’